I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 8 studies | 24% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 8 studies | 24% ± 8% |
Insufficient scRNA-seq data for expression of DNAAF8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 80.09 | 244 / 245 | 88% | 1.68 | 441 / 502 |
| brain | 99% | 98.05 | 2628 / 2642 | 84% | 1.96 | 594 / 705 |
| breast | 98% | 49.24 | 449 / 459 | 76% | 2.64 | 851 / 1118 |
| ovary | 99% | 74.50 | 179 / 180 | 64% | 1.61 | 276 / 430 |
| kidney | 100% | 71.10 | 89 / 89 | 46% | 1.00 | 413 / 901 |
| thymus | 100% | 100.40 | 653 / 653 | 30% | 0.54 | 184 / 605 |
| lung | 94% | 148.29 | 542 / 578 | 37% | 0.90 | 422 / 1155 |
| adrenal gland | 98% | 71.19 | 253 / 258 | 31% | 0.47 | 71 / 230 |
| uterus | 100% | 86.27 | 170 / 170 | 24% | 0.58 | 110 / 459 |
| pancreas | 98% | 41.64 | 322 / 328 | 19% | 0.33 | 33 / 178 |
| liver | 98% | 42.23 | 222 / 226 | 11% | 0.18 | 46 / 406 |
| bladder | 100% | 44.19 | 21 / 21 | 9% | 0.15 | 44 / 504 |
| esophagus | 96% | 42.90 | 1389 / 1445 | 11% | 0.16 | 20 / 183 |
| stomach | 98% | 40.21 | 352 / 359 | 8% | 0.12 | 24 / 286 |
| intestine | 96% | 43.75 | 930 / 966 | 6% | 0.09 | 29 / 527 |
| spleen | 99% | 35.63 | 238 / 241 | 0% | 0 | 0 / 0 |
| skin | 89% | 27.88 | 1619 / 1809 | 9% | 0.12 | 42 / 472 |
| adipose | 96% | 43.03 | 1155 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 95% | 35.68 | 1267 / 1335 | 0% | 0 | 0 / 0 |
| heart | 84% | 24.31 | 720 / 861 | 0% | 0 | 0 / 0 |
| muscle | 81% | 25.22 | 653 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 24% | 5.95 | 221 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 10% | 0.13 | 8 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.05 | 2 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0036158 | Biological process | outer dynein arm assembly |
| GO_0120293 | Cellular component | dynein axonemal particle |
| GO_0070840 | Molecular function | dynein complex binding |
| Gene name | DNAAF8 |
| Protein name | Dynein axonemal assembly factor 8 (Dynein axonemal-associated protein 1) |
| Synonyms | DAAP1 C16orf71 |
| Description | FUNCTION: In cyliated cells, dynein axonemal particle-specific protein required for deployment of ODA to the axoneme. Interacts with outer dynein arm (ODA) subunits. . FUNCTION: In cyliated cells, dynein axonemal particle-specific protein required for deployment of ODA to the axoneme. Interacts with outer dynein arm (ODA) subunits. . FUNCTION: In cyliated cells, dynein axonemal particle-specific protein required for deployment of ODA to the axoneme. Interacts with outer dynein arm (ODA) subunits. . FUNCTION: In cyliated cells, dynein axonemal particle-specific protein required for deployment of ODA to the axoneme. Interacts with outer dynein arm (ODA) subunits. . |
| Accessions | ENST00000619274.1 ENST00000590191.1 ENST00000299320.10 ENST00000586724.5 Q8IYS4 A0A087WT50 K7EPW6 K7ENX3 |
